Sriram Ryali - Mar 14, 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Chief Financial Officer
Signature
/s/ Sriram Ryali
Stock symbol
EIGR
Transactions as of
Mar 14, 2022
Transactions value $
-$12,683
Form type
4
Date filed
3/14/2022, 09:22 PM
Previous filing
Mar 11, 2022
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale -$12.7K -2.27K -5.17% $5.60 41.6K Mar 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares.